Skip to main content

Table 2 Comparison of laboratory indicators between endoscopic remission group and endoscopic activity group in Training and Test Cohort

From: Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn’s disease

Variable

Training Cohort (n = 210)

Test Cohort (n = 90)

Endoscopic Remission

(n = 54)

Endoscopic Activity

(n = 156)

P value

Endoscopic Remission

(n = 21)

Endoscopic Activity

(n = 69)

P value

CDAI

77 (49-100.25)

130 (92-166.75)

< 0.05

70 (40.5–94.5)

149 (99–203)

< 0.05

HB (g/L)

140 (122-150.25)

121.5 (108.3-138.8)

< 0.05

141 (112.5–141)

123 (105–135)

< 0.05

WBC(×109/L)

5.41 (4.28–6.46)

5.5 (4.27–7.28)

0.484

5.99 (4.56–6.67)

6.24 (5.2–8.43)

0.144

 N (×109/L)

3.17 (2.45–4.02)

3.57 (2.69–5.04)

< 0.05

3.05 (2.69–3.53)

4.18 (3.23–5.92)

< 0.05

 L (×109/L)

1.52 (1.1–2.3)

1.2 (0.86–1.57)

< 0.05

2.04 (1.34–2.6)

1.39 (0.99–1.92)

< 0.05

PLT (×109/L)

205 (170.75–233.5)

247.5 (200-315.5)

< 0.05

211 (176.5-231.5)

273 (231–331)

< 0.05

CRP (mg/L)

0.77 (0.5–3.48)

13.9 (4.65–37.62)

< 0.05

1.21 (0.38–4.53)

9.47 (3.22–34.3)

< 0.05

ALB (g/L)

41.35 (38.38–44.1)

37.35 (33.2–41.8)

< 0.05

45.9 (42.8–47.7)

41.5 (36.2–44.8)

< 0.05

NLR

2.1 (1.38–3.27)

3.01 (2.06–4.78)

< 0.05

1.76 (1.11–2.41)

2.94 (2.12–4.79)

< 0.05

PLpR

6.27 (5.11–9.3)

11.5 (7-19.33)

< 0.05

5.57 (4.88–7.84)

12.96 (9.9-17.89)

< 0.05

PLT/ALB

4.88 (4.06–5.89)

6.38 (4.96–8.86)

< 0.05

4.6 (3.7–5.63)

7.48 (5.72–8.84)

< 0.05

CRP/ALB

0.02 (0.01–0.09)

0.36 (0.12–1.11)

< 0.05

0.03 (0.01–0.11)

0.26 (0.07–0.89)

< 0.05

  1. CDAI: Crohn’s disease activity index; HB: hemoglobin; WBC: white blood cell; N: neutrophil; L: lymphocyte; PLT: platelet; CRP: C-reactive protein; ALB: albumin; NLR: neutrophil-to-lymphocyte ratio; PLpR: platelet-to-lymphocyte percentage ratio